|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 15, 2015 ) Dallas, TX -- According to WHO, CKD is not only common, treatable, and harmful but also a major contributing factor to the incidence and outcomes of at least three of the diseases that are targeted by WHO (hypertension, diabetes, and CVD). CKD is mainly defined as a reduced GFR, increased urinary albumin excretion, or both, and is growing public health issue. CKD is classified into five stages (stages 1-5) according to renal function and the level of urinary protein excretion as measured by eGFR which is derived from race, gender, age, and serum creatinine concentration.
Analysts forecast the Global CKD Drugs market to grow at a CAGR of 1.21 percent over the period 2014-2019.
Covered in this Report
The Global CKD Drugs Market can be divided into two segments: Route of Administration which includes oral, SC, and IV and Mechanism of Action which includes ARBs, ACEIs, ESAs, PH Binders, and Vasodilators. This report covers the present scenario and the growth prospects of the Global CKD Drugs market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of CKD that are available in the market.
The report Global CKD Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA and APAC regions; it also covers the Global CKD Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Buy Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=310384 .
Key Regions
Americas
EMEA
APAC
Key Vendors
Actavis PLC
Amgen Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Sanofi
Other Prominent Vendors
Abbott Laboratories
Akebia Therapeutics
AMAG Pharmaceuticals
Cara Therapeutics
FibroGen
Keryx Biopharmaceuticals
Reata Pharmaceuticals
OPKO Health
Pharmacosmos
Raptor Pharmaceuticals
Regulus Therapeutics
Rockwell Medical
Shield Therapeutics
Takeda Pharmaceuticals
Vifor Pharma Ltd
Xenetic Biosciences
ZS Pharma
Inquire Before Buying @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=310384 .
Market Driver
Increase in Associated Disorders with CKD
Market Challenge
Genericization of Major Brands
Market Trend
Approval of New Pipeline Drugs
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=310384 .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Public Safety LTE & Mobile Broadband Market
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
